miR-200c-3p: An Adjunct Chronic Heart Failure Risk Marker Modulating Cardiomyocyte Hypertrophic Transcription and Cardiac Fibroblast Fibrosis.
This study evaluated circulating microRNA-200c-3p (miR-200c-3p) for diagnosis and prognosis in chronic heart failure (CHF) and its regulatory roles in cardiomyocyte hypertrophy and myocardial fibrosis in vitro. A single-center prospective cohort included 150 CHF patients and 80 healthy controls, with CHF stratified int...